home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  


  September, 14 2004 10:35
your information resource in human molecular genetics
PRINCETON, N.J., Sep. 9, 2004 - Orchid BioSciences, Inc. (Nasdaq: ORCH), a leading worldwide supplier of DNA identity testing services, today announced the launch of its IDSecure™ service designed to ensure that workers on high-risk assignments can be accurately identified in the event of an emergency or accident. The new service allows companies to offer employees the opportunity to store unique genetic identifiers in a confidential and safe setting for use only in the event that their identity cannot be verified by other means. Orchid has already partnered with another services firm to provide IDSecure to a major employer of workers on overseas assignment, and is now offering the IDSecure service to private and public sector employers worldwide.

“Orchid’s long history of leadership in applying the latest developments in DNA technology to identity testing has enabled us to help provide innovative solutions in a wide variety of areas that include solving difficult criminal cases, identifying victims of the World Trade Center attacks, and working to identify past historical figures including Christopher Columbus,” said Paul J. Kelly, M.D., chief executive officer of Orchid. “We are proud now to offer IDSecure to the large numbers of people working in potentially dangerous situations around the world.”

Through its Cellmark and GeneScreen businesses in the U.S. and Europe, Orchid has provided rapid, accurate and secure identity testing services for hundreds of thousands of individuals since 1987. Its customers include a broad mix of law enforcement and criminal justice agencies, social service organizations, corporations and private individuals.

Dr. Kelly added, “As a pioneer for almost two decades in expanding the availability of highly accurate and confidential DNA testing services to advance forensic science, parentage determination, immigration and adoption verification, it is fitting that Orchid take the lead in offering the security of DNA identity testing to men and women volunteering for work assignments in high-risk areas and occupations.”

For more information on the IDSecure service, please contact Dale Rutty at 1-800-DNA-TEST (362-8378) or at (716) 523-0553 for callers outside the U.S., or by e-mail at IDSecure@orchid.com.

About Orchid BioSciences, Inc.

Orchid BioSciences is a leading provider of identity genetics services for the forensic and paternity DNA testing markets and for public health and animal DNA testing for food safety. Orchid’s strong market positions in these segments leverage the Company’s accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the world-renowned Cellmark and GeneScreen brands that have been associated with exceptional quality, reliability, innovation and customer service for nearly two decades. More information on Orchid can be found at www.orchid.com.

Information contained in our press releases should be considered accurate only as of the date of the release. Information in any press release may be superseded by more recent information we have disclosed in later press releases, filings with the Securities and Exchange Commission or otherwise. Press releases may contain forward-looking statements based on the expectations of our management as of the date of the release. Actual results may materially differ based on several factors, including those described in the press release.

Message posted by: Frank S. Zollmann

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.